Upper Respiratory Infections
CDC perspective on non-O157 Shiga toxin-producing E. coli (STEC) in the United States Patricia M. Griffin, M.D. Chief, Enteric Diseases Epidemiology Branch.
Cost Effective Management of Influenza-like Illness in the Neuraminidase Inhibitor Era Wallace Greene, PhD, ABMM Director, Diagnostic Virology Laboratory.
Confirmatory Testing of NAATs SHOULD be Routine for Chlamydia Infections in Populations with < 4% Prevalence Harold C. Wiesenfeld, M.D.,C.M. University.
Directed therapy for fungal infections - latest advances Rosemary Barnes Focus on aspergillosis.
Towards an ART-less Future The Challenge of a Cure for HIV Infection David M. Margolis, MD Professor of Medicine, Microbiology & Immunology, Epidemiology.
E. coli O157:H7 -- Illness trends and recent data from outbreak investigations, United States Shiga Toxin –Producing E. coli Addressing the Challenges,
Natural History of Picornavirus Colds in Adults
Effective and Appropriate Antimicrobial Therapy for Intra-abdominal Infections.
Directed therapy for fungal infections - latest advances
